Insider Transactions in Q4 2021 at Standard Biotools Inc. (LAB)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2021
|
Stephen Christopher Linthwaite President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,287
-3.46%
|
$45,148
$4.49 P/Share
|
|
Nov 20
2021
|
Stephen Christopher Linthwaite President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,417
+2.29%
|
-
|
|
Nov 20
2021
|
Vikram Jog Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,378
-1.79%
|
$9,512
$4.49 P/Share
|
|
Nov 20
2021
|
Vikram Jog Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,877
+1.73%
|
-
|
|
Nov 20
2021
|
Nicholas Khadder SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,014
-2.48%
|
$8,056
$4.49 P/Share
|
|
Nov 20
2021
|
Nicholas Khadder SVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
4,063
+4.76%
|
-
|
|
Nov 20
2021
|
Bradley Allen Kreger SVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,680
-3.0%
|
$10,720
$4.49 P/Share
|
|
Nov 20
2021
|
Bradley Allen Kreger SVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,751
+2.89%
|
-
|
|
Nov 20
2021
|
Colin Mc Cracken Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,530
-5.36%
|
$14,120
$4.49 P/Share
|
|
Nov 20
2021
|
Colin Mc Cracken Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,519
+3.29%
|
-
|